164 related articles for article (PubMed ID: 35917917)
1. β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3.
Bourgeat P; Doré V; Burnham SC; Benzinger T; Tosun D; Li S; Goyal M; LaMontagne P; Jin L; Rowe CC; Weiner MW; Morris JC; Masters CL; Fripp J; Villemagne VL;
Neuroimage; 2022 Nov; 262():119527. PubMed ID: 35917917
[TBL] [Abstract][Full Text] [Related]
2. Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies.
Bourgeat P; Doré V; Doecke J; Ames D; Masters CL; Rowe CC; Fripp J; Villemagne VL;
Neuroimage; 2021 Feb; 226():117593. PubMed ID: 33248259
[TBL] [Abstract][Full Text] [Related]
3. Implementing the centiloid transformation for
Bourgeat P; Doré V; Fripp J; Ames D; Masters CL; Salvado O; Villemagne VL; Rowe CC;
Neuroimage; 2018 Dec; 183():387-393. PubMed ID: 30130643
[TBL] [Abstract][Full Text] [Related]
4. Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal Analyses.
Ruwanpathirana GP; Williams RC; Masters CL; Rowe CC; Johnston LA; Davey CE
J Nucl Med; 2024 May; 65(5):781-787. PubMed ID: 38575189
[TBL] [Abstract][Full Text] [Related]
5. Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach.
Royse SK; Minhas DS; Lopresti BJ; Murphy A; Ward T; Koeppe RA; Bullich S; DeSanti S; Jagust WJ; Landau SM;
Alzheimers Res Ther; 2021 May; 13(1):99. PubMed ID: 33971965
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal head-to-head comparison of
Chen CD; McCullough A; Gordon B; Joseph-Mathurin N; Flores S; McKay NS; Hobbs DA; Hornbeck R; Fagan AM; Cruchaga C; Goate AM; Perrin RJ; Wang G; Li Y; Shi X; Xiong C; Pontecorvo MJ; Klein G; Su Y; Klunk WE; Jack C; Koeppe R; Snider BJ; Berman SB; Roberson ED; Brosch J; Surti G; Jiménez-Velázquez IZ; Galasko D; Honig LS; Brooks WS; Clarnette R; Wallon D; Dubois B; Pariente J; Pasquier F; Sanchez-Valle R; Shcherbinin S; Higgins I; Tunali I; Masters CL; van Dyck CH; Masellis M; Hsiung R; Gauthier S; Salloway S; Clifford DB; Mills S; Supnet-Bell C; McDade E; Bateman RJ; Benzinger TLS;
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2669-2682. PubMed ID: 37017737
[TBL] [Abstract][Full Text] [Related]
7. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.
Landau SM; Fero A; Baker SL; Koeppe R; Mintun M; Chen K; Reiman EM; Jagust WJ
J Nucl Med; 2015 Apr; 56(4):567-74. PubMed ID: 25745095
[TBL] [Abstract][Full Text] [Related]
8. Harmonizing florbetapir and PiB PET measurements of cortical Aβ plaque burden using multiple regions-of-interest and machine learning techniques: An alternative to the Centiloid approach.
Chen K; Ghisays V; Luo J; Chen Y; Lee W; Wu T; Reiman EM; Su Y
Alzheimers Dement; 2024 Mar; 20(3):2165-2172. PubMed ID: 38276892
[TBL] [Abstract][Full Text] [Related]
9. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
[TBL] [Abstract][Full Text] [Related]
10. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
Jovalekic A; Roé-Vellvé N; Koglin N; Quintana ML; Nelson A; Diemling M; Lilja J; Gómez-González JP; Doré V; Bourgeat P; Whittington A; Gunn R; Stephens AW; Bullich S
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3276-3289. PubMed ID: 37300571
[TBL] [Abstract][Full Text] [Related]
11. Operationalizing the centiloid scale for [
Coath W; Modat M; Cardoso MJ; Markiewicz PJ; Lane CA; Parker TD; Keshavan A; Buchanan SM; Keuss SE; Harris MJ; Burgos N; Dickson J; Barnes A; Thomas DL; Beasley D; Malone IB; Wong A; Erlandsson K; Thomas BA; Schöll M; Ourselin S; Richards M; Fox NC; Schott JM; Cash DM;
Alzheimers Dement (Amst); 2023; 15(2):e12434. PubMed ID: 37201176
[TBL] [Abstract][Full Text] [Related]
12. Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden.
Bourgeat P; Krishnadas N; Doré V; Mulligan R; Tyrrell R; Bozinovski S; Huang K; Fripp J; Villemagne VL; Rowe CC
J Prev Alzheimers Dis; 2023; 10(2):251-258. PubMed ID: 36946452
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.
Landau SM; Breault C; Joshi AD; Pontecorvo M; Mathis CA; Jagust WJ; Mintun MA;
J Nucl Med; 2013 Jan; 54(1):70-7. PubMed ID: 23166389
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies.
Bollack A; Markiewicz PJ; Wink AM; Prosser L; Lilja J; Bourgeat P; Schott JM; Coath W; Collij LE; Pemberton HG; Farrar G; Barkhof F; Cash DM;
Neuroimage; 2023 Oct; 280():120313. PubMed ID: 37595816
[TBL] [Abstract][Full Text] [Related]
15. rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data.
Iaccarino L; La Joie R; Koeppe R; Siegel BA; Hillner BE; Gatsonis C; Whitmer RA; Carrillo MC; Apgar C; Camacho MR; Nosheny R; Rabinovici GD;
Neuroimage; 2022 Feb; 246():118775. PubMed ID: 34890793
[TBL] [Abstract][Full Text] [Related]
16. Centiloid scaling for quantification of brain amyloid with [
Battle MR; Pillay LC; Lowe VJ; Knopman D; Kemp B; Rowe CC; Doré V; Villemagne VL; Buckley CJ
EJNMMI Res; 2018 Dec; 8(1):107. PubMed ID: 30519791
[TBL] [Abstract][Full Text] [Related]
17. A universal neocortical mask for Centiloid quantification.
Bourgeat P; Doré V; Rowe CC; Benzinger T; Tosun D; Goyal MS; LaMontagne P; Jin L; Weiner MW; Masters CL; Fripp J; Villemagne VL; ;
Alzheimers Dement (Amst); 2023; 15(3):e12457. PubMed ID: 37492802
[TBL] [Abstract][Full Text] [Related]
18. Software development for quantitative analysis of brain amyloid PET.
Matsuda H; Yamao T
Brain Behav; 2022 Mar; 12(3):e2499. PubMed ID: 35134278
[TBL] [Abstract][Full Text] [Related]
19. Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale.
Navitsky M; Joshi AD; Kennedy I; Klunk WE; Rowe CC; Wong DF; Pontecorvo MJ; Mintun MA; Devous MD
Alzheimers Dement; 2018 Dec; 14(12):1565-1571. PubMed ID: 30006100
[TBL] [Abstract][Full Text] [Related]
20. Optimal Reference Region to Measure Longitudinal Amyloid-β Change with
Bullich S; Villemagne VL; Catafau AM; Jovalekic A; Koglin N; Rowe CC; De Santi S
J Nucl Med; 2017 Aug; 58(8):1300-1306. PubMed ID: 28183994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
